Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Vitrafy Life Sciences Ltd. ( (AU:VFY) ) is now available.
Vitrafy Life Sciences Limited announced the release of 276,274 fully paid ordinary shares from mandatory escrow, effective 8 April 2025. These shares will be subject to voluntary escrow, with 25% released after the 2025 financial year’s audited accounts and 75% after the 2026 financial year’s audited accounts. This move is part of Vitrafy’s strategy to manage its securities and maintain investor confidence, potentially impacting its market positioning and stakeholder relations.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited is a Melbourne-based company specializing in cryopreservation solutions. They offer a proprietary range of smart cryopreservation hardware and Lifechain™, a cloud-based software platform, ensuring the preservation of biomaterial quality. Their innovative approach integrates cutting-edge technology and seamless software to optimize cryopreservation, maintaining the integrity of sensitive biological samples. Vitrafy operates an ISO13485 accredited manufacturing facility and laboratory in Ballarat, Victoria, and is listed on the Australian Securities Exchange.
YTD Price Performance: -23.53%
Average Trading Volume: 27,796
See more insights into VFY stock on TipRanks’ Stock Analysis page.